CRA experts advised two parties during both the CMA’s investigation and CAT Appeals, assessing the economic evidence and providing expert testimony on what prices could be considered excessive (or, to the contrary, consistent with competitive outcomes) in the UK market for Liothyronine tablets.
Former DOJ economist Goldstein moves to Charles River Associates
FTCWatch recently conducted an in-depth interview with Vice President Nate Goldstein, exploring his transition from a distinguished 23-year tenure at the...